New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
